Sign in

CIK 0000885590 · Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
operating
Phone
514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. 4 Grant or award Director acquired 45,871 shares (grant or award)
  2. 4 Grant or award Director acquired 45,871 shares (grant or award)
  3. 4 Grant or award Director acquired 45,871 shares (grant or award)
  4. 4 Grant or award Director acquired 45,871 shares (grant or award)
  5. 4 Grant or award Director acquired 45,871 shares (grant or award)
  6. 4 Grant or award Director acquired 45,871 shares (grant or award)
  7. 4 Planned sale Director sold 24,456 shares at $5.43 ($132,796)
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Shareholder vote results
  10. 144 Insider Sale of Securities
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. ARS Other Annual Report to Security Holders
  14. DEFA14A Proxy Proxy Materials
  15. DEF 14A Proxy Proxy Statement
  16. 4 Grant or award Director acquired 5,946 shares (grant or award)
  17. 4 Grant or award Director acquired 11,574 shares (grant or award)
  18. 4 Grant or award Director acquired 1,273 shares (grant or award)
  19. 4 Shares withheld for taxes EVP, CFO gave up 49,060 shares (to pay taxes)
  20. 4 Planned sale EVP, General Counsel sold 11,276 shares at an average $5.78 ($65,131)

Page 2 of 121 · 2,419 filings